EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Autophagy Activators Normalize Aberrant Tau Proteostasis and Rescue Synapses in Human Familial Alzheimer's Disease iPSC‐Derived Cortical Organoids

Sergio R Labra iD, Jadon Compher iD, Akhil Prabhavalkar iD, Mireya Almaraz, Claudia Cedeño Kwong iD, Christine Baal iD, Maria Talantova iD, Nima Dolatabadi, Julian Piña-Sanz, Yubo Wang, Leonard Yoon iD, Swagata Ghatak iD und 12 weitere

Advanced Science · 2026

DOI: 10.1002/advs.202514783 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Sergio R Labra und 23 weiteren Autor:innen. Beteiligte Einrichtung: Neurodegeneration New Medicines Center, The Scripps Research Institute, La Jolla, California, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Induced Pluripotent Stem Cells, Autophagy, tau Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIA NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is the leading cause of dementia worldwide. Nevertheless, its cellular and molecular mechanisms remain incompletely understood, partially due to inadequate disease models. To illuminate early changes in AD, we developed a cerebrocortical organoid (CO) model with improved methodology. Our COs produce excitatory and inhibitory neurons alongside glia, utilizing established isogenic wild‐type and diseased human induced pluripotent stem cells (hiPSCs) carrying heterozygous familial AD mutations in PSEN1 ΔE9 /WT, PSEN1 M146V /WT, or APP Swe /WT. In addition to amyloid‐beta (Aβ) accumulation, the AD COs display time‐progressive loss of monomeric Tau, and accumulation of aggregated high‐molecular‐weight (HMW) phospho(p)‐Tau species (pT181 and pT217). They also exhibit neuronal hyperexcitability reminiscent of early electroencephalography (EEG) clinical findings and synapse loss in AD patient brains. Single‐cell RNA‐sequencing analyses of AD and WT control COs reveal significant divergent molecular abnormalities in excitatory vs. inhibitory neurons, with several pathways being upregulated in one while downregulated in the other, providing insight into AD phenotypes. Finally, we show that chronic dosing with autophagy activators, including a novel mTOR inhibitor‐independent drug candidate, prevents pathologic Aβ and HMW p‐Tau accumulation, normalizes hyperexcitability, and rescues synaptic loss in AD COs. Collectively, our results demonstrate this CO model as a useful platform for assessing early features of familial AD pathogenesis and for testing small‐molecule candidate therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseInduced Pluripotent Stem CellsAutophagytau ProteinsOrganoidsSynapsesProteostasisHumansCerebral Cortex

Stichwörter der Autor:innen

Alzheimer's diseaseautophagycortical organoidspTau oligomerspresenilin 1

Substanzen

tau Proteins

Autor:innen und Institutionen

  • Neurodegeneration New Medicines Center, The Scripps Research Institute, La Jolla, California, USA.
  • Department of Molecular and Cellular Biology, The Scripps Research Institute, La Jolla, California, USA.
  • Department of Chemistry, The Scripps Research Institute, La Jolla, California, USA.
  • School of Biological Sciences, National Institute of Science Education and Research, Bhubaneswar, Odisha, India.
  • Translational Genomics Research Institute, Phoenix, Arizona, USA.
  • Genomics Core, The Scripps Research Institute, La Jolla, California, USA.

ORCID-Profile: Sergio R Labra, Jadon Compher, Akhil Prabhavalkar, Claudia Cedeño Kwong, Christine Baal, Maria Talantova, Leonard Yoon, Swagata Ghatak, Zi Gao, Dorit Trudler, Lynee Massey, Anthony Balistreri, Michael Bula, Nicholas J Schork, Steven R Head, Stuart A Lipton

Förderung

  • NIH HHS
  • NIA NIH HHS
  • National Institutes of Health

Zitieren

APA

Labra, S. R., Compher, J., Prabhavalkar, A., Almaraz, M., Cedeño Kwong, C., Baal, C., Talantova, M., Dolatabadi, N., Piña-Sanz, J., Wang, Y., Yoon, L., Ghatak, S., Gao, Z., Zhang, Y., Trudler, D., Massey, L., Lin, W., Balistreri, A., Bula, M., …, & Lipton, S. A. (2026). Autophagy Activators Normalize Aberrant Tau Proteostasis and Rescue Synapses in Human Familial Alzheimer's Disease iPSC‐Derived Cortical Organoids. Advanced Science. https://doi.org/10.1002/advs.202514783

Vancouver

Labra SR, Compher J, Prabhavalkar A, Almaraz M, Cedeño Kwong C, Baal C, et al. Autophagy Activators Normalize Aberrant Tau Proteostasis and Rescue Synapses in Human Familial Alzheimer's Disease iPSC‐Derived Cortical Organoids. Advanced Science. 2026. doi:10.1002/advs.202514783

BibTeX
@article{Labra2026,
  author = {Labra, Sergio R and Compher, Jadon and Prabhavalkar, Akhil and Almaraz, Mireya and Cedeño Kwong, Claudia and Baal, Christine and Talantova, Maria and Dolatabadi, Nima and Piña-Sanz, Julian and Wang, Yubo and Yoon, Leonard and Ghatak, Swagata and Gao, Zi and Zhang, Yuting and Trudler, Dorit and Massey, Lynee and Lin, Wei and Balistreri, Anthony and Bula, Michael and Schork, Nicholas J and Mondala, Tony S and Head, Steven R and Kelly, Jeffery W and Lipton, Stuart A},
  title = {Autophagy Activators Normalize Aberrant Tau Proteostasis and Rescue Synapses in Human Familial Alzheimer's Disease iPSC‐Derived Cortical Organoids},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202514783}
}
Kostenlos starten →